INNOVATIVE EYEWEAR, INC. Operating Cash Flow
INNOVATIVE EYEWEAR, INC. (LUCY) reported Operating Cash Flow of -$4.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.86M.
- INNOVATIVE EYEWEAR, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.49M.
- INNOVATIVE EYEWEAR, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.35M.
- INNOVATIVE EYEWEAR, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.50M.
- INNOVATIVE EYEWEAR, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$7.28M.
- INNOVATIVE EYEWEAR, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$6.74M.
- INNOVATIVE EYEWEAR, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$5.77M.
- INNOVATIVE EYEWEAR, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$3.22M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$4.35M 10-Q · filed 2026-08-14 | -$5.71M derived: sum of 3 quarters · filed 2026-08-14 | -$7.20M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$2.49M 10-Q · filed 2026-05-14 | -$3.84M derived: sum of 2 quarters · filed 2026-05-14 | -$5.34M derived: sum of 3 quarters · filed 2026-05-14 | -$7.45M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$2.85M derived: sum of 2 quarters · filed 2026-03-25 | -$4.96M derived: sum of 3 quarters · filed 2026-08-14 | -$7.28M 10-K · filed 2026-03-25 | |||
| 2025-09-30 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$3.61M derived: sum of 2 quarters · filed 2026-08-14 | -$5.92M 10-Q · filed 2025-11-13 | -$7.87M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$4.43M 10-Q · filed 2026-08-14 | -$6.37M derived: sum of 3 quarters · filed 2026-08-14 | -$7.77M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$2.31M 10-Q · filed 2026-05-14 | -$4.25M derived: sum of 2 quarters · filed 2026-05-14 | -$5.65M derived: sum of 3 quarters · filed 2026-05-14 | -$7.58M derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$3.34M derived: sum of 2 quarters · filed 2026-03-25 | -$5.27M derived: sum of 3 quarters · filed 2026-03-25 | -$6.74M 10-K · filed 2026-03-25 | |||
| 2024-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$3.33M derived: sum of 2 quarters · filed 2025-11-13 | -$4.80M 10-Q · filed 2025-11-13 | -$6.14M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$3.40M 10-Q · filed 2025-08-14 | -$4.74M derived: sum of 3 quarters · filed 2025-08-14 | -$6.08M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$1.47M 10-Q · filed 2025-05-13 | -$2.81M derived: sum of 2 quarters · filed 2025-05-13 | -$4.15M derived: sum of 3 quarters · filed 2025-05-13 | -$5.87M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$2.68M derived: sum of 2 quarters · filed 2025-03-24 | -$4.40M derived: sum of 3 quarters · filed 2025-03-24 | -$5.77M 10-K · filed 2025-03-24 | |||
| 2023-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$3.06M derived: sum of 2 quarters · filed 2024-11-12 | -$4.43M 10-Q · filed 2024-11-12 | -$4.63M 10-Q · filed 2023-11-14 | -$5.54M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$3.09M 10-Q · filed 2024-08-12 | -$3.27M 10-Q · filed 2023-08-11 | -$4.20M derived: sum of 3 quarters · filed 2024-08-12 | -$5.17M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | -$1.36M 10-Q · filed 2024-05-14 | -$1.43M 10-Q · filed 2023-05-12 | -$2.48M derived: sum of 2 quarters · filed 2024-05-14 | -$3.45M derived: sum of 3 quarters · filed 2024-05-14 | -$3.96M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$2.09M derived: sum of 2 quarters · filed 2024-03-25 | -$2.59M derived: sum of 3 quarters · filed 2024-03-25 | -$3.22M 10-K · filed 2024-03-25 | |||
| 2022-09-30 | -$970.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.48M derived: sum of 2 quarters · filed 2023-11-14 | -$2.11M 10-Q · filed 2023-11-14 | -$2.00M 10-Q · filed 2022-11-10 | -$2.51M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$505.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$1.14M 10-Q · filed 2023-08-11 | -$1.54M derived: sum of 3 quarters · filed 2023-08-11 | -$2.01M derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | -$630.87K 10-Q · filed 2023-05-12 | -$1.03M derived: sum of 2 quarters · filed 2023-05-12 | -$1.50M derived: sum of 3 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$403.71K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$874.08K derived: sum of 2 quarters · filed 2023-03-24 | -$1.21M 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | -$470.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$810.45K 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$340.08K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |